Nuwellis (NASDAQ:NUWE) Trading Up 2.4% – Time to Buy?

Nuwellis, Inc. (NASDAQ:NUWE) shares traded up 2.4% during trading on Wednesday . The company traded as high as $1.11 and last traded at $1.09. 76,039 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 898,355 shares. The stock had previously closed at $1.06.

Nuwellis Stock Performance

The company has a fifty day moving average of $1.50 and a two-hundred day moving average of $2.45. The company has a market cap of $4.75 million, a price-to-earnings ratio of -0.01 and a beta of 0.32.

Nuwellis (NASDAQ:NUWE) last released its quarterly earnings results on Monday, November 11th. The company reported $1.74 earnings per share for the quarter, topping the consensus estimate of ($0.88) by $2.62. Nuwellis had a negative return on equity of 28,159.25% and a negative net margin of 169.54%. The company had revenue of $2.37 million for the quarter, compared to analysts’ expectations of $2.40 million. During the same period in the previous year, the business posted ($63.29) earnings per share. Equities analysts expect that Nuwellis, Inc. will post -9.91 EPS for the current fiscal year.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.